SuppreMol is a biotechnology firm that develops novel therapeutics for the treatment of autoimmune diseases.
Business Model:
Revenue: $14.5M
Employees: 51-200
SuppreMol was acquired by
Baxter International.
The acquisition happend on 2015-03-05.
Details of the transaction were not public
Address: Am Klopferspitz 19a
City: Martinsried
State: bavaria
Zip: 82152
Country: DE
SuppreMol is a biotechnology firm that develops novel therapeutics for the treatment of autoimmune diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Series C | 6 | $20.4M |
Bayern Kapital BioMedPartners FCP Biotech Holding KfW MIG Santo Holding Bayern Kapital BioMedPartners FCP Biotech Holding KfW MIG Santo Holding |
5/2013 | Series D | $12.2M |
MIG AG BioMedPartners AG Max Planck Society |
12/2010 | Series C | $20.5M |
BioMedPartners MIG AG KfW Mittelstandsbank Bayern Kapital Max-Planck-Gesellschaft |
7/2008 | Series B | 6 | $25M |
BioMedPartners MIG Santo Holding Max-Planck-Gesellschaft KfW Bayern Kapital BioMedPartners MIG |
5/2006 | Series A | $0 |
Bayern Kapital KfW Zcube Bayern Kapital KfW Zcube |
9/2012 | Series D | 1 | $8.2M |
MIG MIG |
7/2008 | Series B | $25M |
MIG Verwaltungs AG BioMedPartners AG KfW Mittelstandsbank Bayern Kapital Max-Planck-Gesellschaft ZETACUBE s.r.l |
5/2013 | Series D | 4 | $12.3M |
BioMedPartners FCP Biotech Holding MIG Santo Holding BioMedPartners FCP Biotech Holding MIG Santo Holding |
5/2006 | Series A | 3 | $5.2M |
KfW Mittelstandsbank Bayern Kapital Z-Cube |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|